BiomX Inc. Files 2025 Proxy Statement
Ticker: PHGE · Form: DEF 14A · Filed: Mar 27, 2025 · CIK: 1739174
| Field | Detail |
|---|---|
| Company | Biomx Inc. (PHGE) |
| Form Type | DEF 14A |
| Filed Date | Mar 27, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, corporate-governance
TL;DR
BiomX proxy filed - shareholders vote soon on company matters.
AI Summary
BiomX Inc. filed a definitive proxy statement (DEF 14A) on March 27, 2025, for its annual meeting on April 21, 2025. The company, formerly known as Chardan Healthcare Acquisition Corp., is involved in biological products. The filing details information for shareholders regarding the upcoming meeting and voting matters.
Why It Matters
This filing provides shareholders with crucial information to make informed decisions about company matters and vote at the upcoming annual meeting.
Risk Assessment
Risk Level: low — This is a standard DEF 14A filing, which is routine for publicly traded companies and does not inherently indicate new risks.
Key Players & Entities
- BiomX Inc. (company) — Registrant
- Chardan Healthcare Acquisition Corp. (company) — Former company name
- 20250327 (date) — Filing date
- 20250421 (date) — Meeting date
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing, also known as a Proxy Statement, is used to solicit proxies from shareholders when a company is holding an annual or special meeting of shareholders. It provides detailed information about the matters to be voted on.
When was this DEF 14A filed by BiomX Inc.?
BiomX Inc. filed this DEF 14A on March 27, 2025.
What is the scheduled date for BiomX Inc.'s shareholder meeting?
The proxy statement indicates that the meeting is scheduled for April 21, 2025.
What was BiomX Inc.'s former company name?
BiomX Inc. was formerly known as Chardan Healthcare Acquisition Corp.
What is the SIC code for BiomX Inc.?
The Standard Industrial Classification (SIC) code for BiomX Inc. is 2836, which corresponds to Biological Products (No Diagnostic Substances).
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on March 27, 2025 regarding BiomX Inc. (PHGE).